Alexander (Alex) Karnal is a Partner and Managing Director at Deerfield, and joined the Firm in 2005. He is responsible for portfolio decisions across the Deerfield Funds. Beyond his direct investment activities at the firm, Mr. Karnal helped conceptualize and implement the Cure, Deerfield’s healthcare innovation campus at 345 Park Avenue South. Furthermore, during the Covid-19 global health crisis, Mr. Karnal was appointed by Governor Ned Lamont to the Reopen Connecticut Advisory Group to provide counsel on the reopening of the state’s economy, community, and education systems. He is a co-founder, CEO and board chairman of The Institute for Life Changing Medicines, a nonprofit dedicated to saving one million people suffering from life-threatening and devastating diseases around the world with no barriers to access. Mr. Karnal serves on the Boards of the New York Academy of Medicine, Biotechnology Innovation Organization, Recovery Centers of America and Discovery Labs, the latter two for which he is a co-founder. He is a member of the Massachusetts Institute of Technology’s corporate development committee, focusing on student life initiatives. Prior to Deerfield, he was a member of Merrill Lynch’s Global Equity Linked Products Group and of its Capital Markets team. Mr. Karnal was featured in the April 2020 edition of “The 20 under 40: Inside the next generation of biopharma leaders – Endpoints News.” He holds a B.S. in Finance from the Massachusetts Institute of Technology and M.S. in Biotechnology from Johns Hopkins University.